Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Current Assets: 2018-2020

Historic Current Assets for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2020 value amounting to $319.6 million.

  • Black Diamond Therapeutics' Current Assets fell 28.20% to $241.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $241.5 million, marking a year-over-year decrease of 28.20%. This contributed to the annual value of $319.6 million for FY2020, which is 105.22% up from last year.
  • As of FY2020, Black Diamond Therapeutics' Current Assets stood at $319.6 million, which was up 105.22% from $155.7 million recorded in FY2019.
  • In the past 5 years, Black Diamond Therapeutics' Current Assets ranged from a high of $319.6 million in FY2020 and a low of $51.7 million during FY2018.
  • Over the past 3 years, Black Diamond Therapeutics' median Current Assets value was $155.7 million (recorded in 2019), while the average stood at $175.7 million.
  • Data for Black Diamond Therapeutics' Current Assets shows a peak YoY soared of 201.28% (in 2019) over the last 5 years.
  • Over the past 3 years, Black Diamond Therapeutics' Current Assets (Yearly) stood at $51.7 million in 2018, then surged by 201.28% to $155.7 million in 2019, then skyrocketed by 105.22% to $319.6 million in 2020.